Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Monda

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Urology|February 4, 2026
Editorial CommentBenjamin Pockros, Steven Monda
Urology|February 15, 2026
Editorial Comment on "Homologous Recombination Repair Mutations, Next-Generation Sequencing Testing, and Treatment Progression by Race Among Patients with Metastatic Castration-Sensitive Prostate Cancer"Joshua Cockrum, Steven Monda
The Journal of Urology|December 24, 2025
Editorial CommentMadison Krischak, Steven Monda
Kidney Cancer (Clifton, Va.)|September 12, 2024
Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic ReviewSteven Monda, Primo N Lara, Shuchi Gulati
European Urology Focus|September 18, 2023
Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and SurgerySteven Monda, Manolis Pratsinis, Hansen Lui, et al.
Journal of Clinical Medicine|May 27, 2026
Histologic Heterogeneity of Metastases in Clear Cell Renal Cell Carcinoma with Sarcomatoid DifferentiationKaitlin Berry, William Paul Skelton, Madison Karabinus, et al.
Journal of Endourology|December 2, 2020
<i>Ex Vivo</i> Porcine Model for Robot-Assisted Partial Nephrectomy Simulation at a High-Volume Tertiary Center: Resident Perception and Validation Assessment Using the Global Evaluative Assessment of Robotic Skills ToolAlexander K Chow, Ryan Wong, Steven Monda, et al.
Clinical Genitourinary Cancer|November 3, 2025
Pathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial CarcinomaEugene Oh, Ye Chua, Piroz Bahar, et al.
Research Square|October 3, 2025
Molecular Profiling of Primary versus Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma Reveals Heterogeneity in Tumor Immune MicroenvironmentBrittney Cotta, Srinivas Nallandhighal, Steven Monda, et al.
Scientific Reports|January 28, 2026
Molecular profiling of primary versus paired asynchronous metastatic clear cell renal cell carcinoma reveals heterogeneity in tumor immune microenvironmentBrittney Cotta, Srinivas Nallandhighal, Steven Monda, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Urology|February 4, 2026
Editorial CommentBenjamin Pockros, Steven Monda
Urology|February 15, 2026
Editorial Comment on "Homologous Recombination Repair Mutations, Next-Generation Sequencing Testing, and Treatment Progression by Race Among Patients with Metastatic Castration-Sensitive Prostate Cancer"Joshua Cockrum, Steven Monda
The Journal of Urology|December 24, 2025
Editorial CommentMadison Krischak, Steven Monda
Kidney Cancer (Clifton, Va.)|September 12, 2024
Post-Metastasectomy Adjuvant Therapy in Patients with Renal Cell Carcinoma: A Systematic ReviewSteven Monda, Primo N Lara, Shuchi Gulati
European Urology Focus|September 18, 2023
Secondary Bladder Cancer After Prostate Cancer Treatment: An Age-matched Comparison Between Radiation and SurgerySteven Monda, Manolis Pratsinis, Hansen Lui, et al.
Journal of Clinical Medicine|May 27, 2026
Histologic Heterogeneity of Metastases in Clear Cell Renal Cell Carcinoma with Sarcomatoid DifferentiationKaitlin Berry, William Paul Skelton, Madison Karabinus, et al.
Journal of Endourology|December 2, 2020
<i>Ex Vivo</i> Porcine Model for Robot-Assisted Partial Nephrectomy Simulation at a High-Volume Tertiary Center: Resident Perception and Validation Assessment Using the Global Evaluative Assessment of Robotic Skills ToolAlexander K Chow, Ryan Wong, Steven Monda, et al.
Clinical Genitourinary Cancer|November 3, 2025
Pathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial CarcinomaEugene Oh, Ye Chua, Piroz Bahar, et al.
Research Square|October 3, 2025
Molecular Profiling of Primary versus Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma Reveals Heterogeneity in Tumor Immune MicroenvironmentBrittney Cotta, Srinivas Nallandhighal, Steven Monda, et al.
Scientific Reports|January 28, 2026
Molecular profiling of primary versus paired asynchronous metastatic clear cell renal cell carcinoma reveals heterogeneity in tumor immune microenvironmentBrittney Cotta, Srinivas Nallandhighal, Steven Monda, et al.
Pageof 1